Literature DB >> 19622298

[Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients].

Shi-Yang Pan1, Er-Fu Xie, Yong-Qian Shu, Li Gao, Li-Xia Zhang, Dan Chen, Jin-Bu Chen, Wen-Jun Zhao, Yuan Mu, Ji-Nan Zhang.   

Abstract

BACKGROUND AND
OBJECTIVE: The protein encoded by adenomatous polyposis coli (APC) gene participates in the signaling transduction pathway. Substantial studies have revealed that hypermethylation of APC gene promoter is closely related to the pathogenesis and development of cancer. This study was to develop a real-time quantitative methylation specific PCR (real-time QMSP) method, and detect the methylation of APC gene promoter in plasma of lung cancer patients.
METHODS: Genomic DNA with methylated APC gene promoter was extracted from the lung cancer cell line NCI-H460 using phenol-chloroform and quantified by spectrophotometric measurements. DNA was added into 200 microL plasma samples of healthy volunteers to make 10-fold serial dilutions. Circulating DNA from simulated plasma samples, 78 lung cancer patients, 31 patients with benign lung diseases and 23 health controls was extracted using magnetic beads and modified by bisulfite. The concentration of cell-free methylated APC gene promoter in the plasma samples was quantified by the external reference method with the standard curve constructed using simulated plasma.
RESULTS: The linear range of the real-time QMSP assay was 1.5x10(2)-1.5x10(5) copies/ mL and its lowest detectability was 1.5x10(2) copies per milliliter plasma. Of 78 lung cancer patients, positive methylation of the APC gene promoter was detected in tumor tissues of 40 cases. Among the 40 lung cancer patients, positive methylation of the APC gene promoter was found in the plasma of 19 patients (47.5%). The concentrations of methylated APC promoter in the 19 lung cancer patients ranged from 1.67x10(2) to 6.78x10(3) copies/mL, with a median concentration of 1.67x10(3) copies/mL. No positive methylation of the APC gene promoter was detected in the plasma of 38 lung cancer patients without APC gene methylation in tissues, 31 benign lung diseases and 23 healthy controls.
CONCLUSIONS: The newly developed real-time QMSP method allows the quantitative measurement of APC gene promoter methylation in plasma. Hypermethylation of the APC gene promoter in plasma is a potential diagnostic marker for lung cancer diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622298

Source DB:  PubMed          Journal:  Ai Zheng


  7 in total

1.  Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.

Authors:  Li Gao; Erfu Xie; Tongfu Yu; Dan Chen; Lixia Zhang; Bingfeng Zhang; Fang Wang; Jian Xu; Peijun Huang; Xisheng Liu; Bingliang Fang; Shiyang Pan
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.

Authors:  Baoli Hu; Hangfeng Zhang; Haitao Wei; Zuopei Wang; Feng Zhang; Xiaolong Wang; Li Li
Journal:  Thorac Cancer       Date:  2017-05-12       Impact factor: 3.500

3.  Circulating nucleic acids as a new diagnostic tool.

Authors:  Marketa Urbanova; Jan Plzak; Hynek Strnad; Jan Betka
Journal:  Cell Mol Biol Lett       Date:  2010-02-25       Impact factor: 5.787

4.  Evaluation of the Biological Efficiency of Silver Nanoparticles Biosynthesized Using Croton tiglium L. Seeds Extract against Azoxymethane Induced Colon Cancer in Rats.

Authors:  Wael Mahmoud Aboulthana; Noha El-Sayed Ibrahim; Noha Mohamed Osman; Mohamed Mahmoud Seif; Amgad Kamal Hassan; Ahmed Mahmoud Youssef; Amal Mostafa El-Feky; A A Madboli
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

5.  APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.

Authors:  Fang Liu; Xiaoling Lu; Xiaoxi Zhou; He Huang
Journal:  Thorac Cancer       Date:  2021-09-20       Impact factor: 3.500

6.  Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer.

Authors:  Hong Wang; Bingfeng Zhang; Dan Chen; Wenying Xia; Jiexin Zhang; Fang Wang; Jian Xu; Yan Zhang; Meijuan Zhang; Lixia Zhang; Yachun Lu; Yan Geng; Peijun Huang; Puwen Huang; Hong Wang; Shiyang Pan
Journal:  Clin Epigenetics       Date:  2015-11-05       Impact factor: 6.551

7.  Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer.

Authors:  Shicheng Guo; Lixing Tan; Weilin Pu; Junjie Wu; Kuan Xu; Jinhui Wu; Qiang Li; Yanyun Ma; Jibin Xu; Li Jin; Jiucun Wang
Journal:  Clin Epigenetics       Date:  2014-03-24       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.